Urinary N-acetyl-/3-glucosaminidase (NAG) and its isoenzymes (NAG A and NAG B) in samplesfrom 87 type 1 diabetic patientsand 40 apparently healthy reference subjects were studied with enzyme immunoassays. The diabetic patients had higher concentrationsof urinary NAG than did the controlsubjects(P <0.01), but the isoenzymepatterndid not differ. There was a positive correlation between metabolic control (Hb A1 concentrations)and total NAG (P <0.01), NAG A (P <0.01), and NAG B (P <0.001). The diabeticpatientswere dMded intothree groups,dependingon the degreeof retinopathy. Subjectswith severe forms of retinopathydid not have increasedconcentrationsof urinary NAG unless they had concomitant nephropathy. (1) (2) (3) (4) (5) (6) (7) (8) (9) , and a positive correlation has been found between these enzymes and the degree of metabolic control (2, 6, 10). Whiting et al. (9) have also reported that treatment of newly diagnosed diabetic patients resulted in decreased excretion of NAG in urine. In addition, positive correlations between these enzymes and the degree of nephropathy (3, 6-8, 10) have also been described, whereas no clear correlation to the degree of retinopathy has been established (2, 5-8, 10, 11).
Increased activities of lysosomal enzymes in urine [e.g., N.acetyl-$-glucosaminidase (NAG); EC 3.2.1.30] have been described in diabetic patients (1) (2) (3) (4) (5) (6) (7) (8) (9) , and a positive correlation has been found between these enzymes and the degree of metabolic control (2, 6, 10). Whiting et al. (9) have also reported that treatment of newly diagnosed diabetic patients resulted in decreased excretion of NAG in urine. In addition, positive correlations between these enzymes and the degree of nephropathy (3, 6-8, 10) have also been described, whereas no clear correlation to the degree of retinopathy has been established (2, 5-8, 10, 11).
The aim of the present study was to examine whether 
MaterIals and Methods

Study Population
Of 72 consecutive patients with well-known proliferative retinopathy (regularly controlled at the Departments of Internal Medicine and Ophthalmology) whom we asked to participate in the study, 45 agreed. The control group consisted of 65 consecutive patients, matched with the study group for duration of diabetes and characterized in previous ophthalmological examinations as having no or mild background retinopathy.
Of these patients, 42 agreed to participate. Thus, 87 patients with type 1 diabetes participated in the study.
The patients were reexamined
by ophthalmoscopy through a dilated pupil. Of the 42 "control" patients examined, 28 still had no or minimal retinopathy with single microaneurysms or hemorrhages; 13 patients had frequent microaneurysms, hemorrhages, or hard exudates, or ischemic zones; one patient had developed proliferative retinopathy. Thus, in these latter "control" patients, the retinopathy had progressed during the preceding one to two years, and they formed a separate group, referred to as the "progressive retinopathy" group, in which the 14 patients had moderate to severe nonproliferative retinopathy.
The reference group consisted of 20 men and 20 women, ages 30-50 years. All were apparently healthy and took no medication. as the ratio between the albumin clearance and the creatinine clearance (normal value <0.01 x 10-s). The urinary albumin and creatinine concentrations were measured in the first morning specimen, and serum albumin and creatunune were measured simultaneously.
AnalyticalTechniques
The methods for determining NAG and its isoenzymes in urine, based on an enzyme immunoassay with monoclonal antibodies, have been described previously (12) . With 
Statistical Methods
For
ResuIts
Patients' Characteristics
Patients' characteristics are shown in Table 1 . The patients were primarily matched for duration of diabetes, and hence this variable was similar in all groups. There were more men than women with mild retinopathy; otherwise, the proportion of men and women was similar.
Patients with proliferative retinopathy were younger than those with mild retinopathy (P <0.001) and had an earlier age at onset than those with mild (P <0.01) or progressive retinopathy (P <0.001). Blood glucose was higher and the insulin dose lower in patients with progressive retinopathy than in those with mild retinopathy (P >0.05 and P <0.001, respectively). Hb A1 concentrations were higher in patients with progressive or proliferative retinopathy than in those with mild retinopathy (P <0.01 and P <0.01, respectively). Systolic blood pressure was similar in all groups, whereas patients with proliferative retinopathy had higher diastolic blood pressure than did those with mild retinopathy (P <0.05). More patients were treated for hypertension if they had progressive or proliferative retinopathy than were those with mild retinopathy (P <0.005 andP <0.001, respectively). The number of smokers was similar in all three groups. The number of patients with proliferative retinopathy was similarly distributed in all three groups (11, 19, and 14, respectively). On the other hand, no patient with mild retinopathy, and only one with The values represent mean ± SEM; abbreviatIonsas in Fig. 1 progressive retinopathy, were among those with high albumin clearances. Among patients with low albumin clearances, total NAG was 1 U/Amol creatinine in all patients but one, whereas NAG was >1 U/mol creatinine in all patients but two among those with higher albumin clearances.
Association between NAG, the degree of metabolic control, and clinical signs of nephropathy. The correlations between total NAG and its isoenzymes, the degree of metabolic control, and clinical signs of nephropathy are shown in Table 3 . Total NAG and NAG A and NAG B were strongly correlated (P <0.001). Moreover, there was a positive correlation between total NAG and its isoenzymes on the one hand, and the degree of metabolic control, albumin clearance, and serum creatinine on the other.
Discussion
To study a possible relationship between urinary NAG and diabetic microangiopathy, i.e., severe retinopathy and nephropathy, we asked consecutive diabetic patients with proliferative retinopathy to participate in the study. Because about 30% of patients with proliferative retinopathy lack clinical signs of nephropathy (14), and 70% have some degree of nephropathy, it was thus possible to study patients with severe retinopathy without signs of nephropathy as well as patients with both types of microangiopathy.
Diabetic patients with no or minimal background Table 2 . Total NAG and Percentage of NAG B Thus, the positive correlation between urinary NAG and nephropathy in other studies could be confirmed (3, [6] [7] [8] 10 ).
However, urinary NAG has not been shown to predict the later development of nephropathy (15) The present study supports the assumption that urinary NAG is associated with poor metabolic control in patients with diabetes meflitus. Long-term poor metabolic control is, in turn, associated with both nephropathy and retinopathy. However, the increased concentrations of urinary NAG in patients with nephropathy could not be explained merely by impaired glucose metabolism because patients with severe retinopathy and no signs of nephropathy had values similar to control patients with no or mild retinopathy. Thus, we found a clear correlation between increased concentrations of urinary NAG and signs of nephropathy that could depend on the renal tubular damage seen in diabetic patients (16-19).
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